Evaluation of the prevalence of metachronous second primary malignancies in hypopharyngeal carcinoma and their effect on outcomes.
Xi LuoXiaodong HuangShaoyan LiuXiaolei WangJingwei LuoJianping XiaoKai WangYuan QuXuesong ChenYe ZhangJingbo WangJianghu ZhangGuozhen XuLi GaoRunye WuJunlin YiPublished in: Cancer medicine (2022)
The overall incidence of Met-SPMs in HPC was 12.3%. The occurrence of Met-SPMs does not jeopardize the survival outcome of HPC. Routine surveillance of Met-SPMs was requisite for patients with HPC.